These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 37180636)

  • 21.
    Pang Y; Zong Z; Huo F; Jing W; Ma Y; Dong L; Li Y; Zhao L; Fu Y; Huang H
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28739779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acquisition of clofazimine resistance following bedaquiline treatment for multidrug-resistant tuberculosis.
    Liu Y; Gao J; Du J; Shu W; Wang L; Wang Y; Xue Z; Li L; Xu S; Pang Y
    Int J Infect Dis; 2021 Jan; 102():392-396. PubMed ID: 33130209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial susceptibility and minimum inhibitory concentration distribution of common clinically relevant non-tuberculous mycobacterial isolates from the respiratory tract.
    He G; Wu L; Zheng Q; Jiang X
    Ann Med; 2022 Dec; 54(1):2500-2510. PubMed ID: 36120867
    [No Abstract]   [Full Text] [Related]  

  • 24. Minimal Inhibitory Concentration of Clofazimine Among Clinical Isolates of Nontuberculous Mycobacteria and Its Impact on Treatment Outcome.
    Kwak N; Whang J; Yang JS; Kim TS; Kim SA; Yim JJ
    Chest; 2021 Feb; 159(2):517-523. PubMed ID: 32712225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of Clinical Isolation Characteristics of Nontuberculous Mycobacteria and Drug Sensitivity of Rapidly Growing Mycobacteria in the General Hospital of Guangzhou, China.
    Liu X; Lin Z; Li Y; Zhong Z; Wu A; Jiang Y
    Infect Drug Resist; 2024; 17():4079-4088. PubMed ID: 39319037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.
    Heidarieh P; Mirsaeidi M; Hashemzadeh M; Feizabadi MM; Bostanabad SZ; Nobar MG; Hashemi Shahraki A
    Microb Drug Resist; 2016 Mar; 22(2):172-8. PubMed ID: 26468990
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Litvinov V; Makarova M; Kudlay D; Nikolenko N; Mikhailova J
    J Med Microbiol; 2021 Oct; 70(10):. PubMed ID: 34668850
    [No Abstract]   [Full Text] [Related]  

  • 28. Arabinosyltransferase C Mediates Multiple Drugs Intrinsic Resistance by Altering Cell Envelope Permeability in Mycobacterium abscessus.
    Wang S; Cai X; Yu W; Zeng S; Zhang J; Guo L; Gao Y; Lu Z; Hameed HMA; Fang C; Tian X; Yusuf B; Chhotaray C; Alam MDS; Zhang B; Ge H; Maslov DA; Cook GM; Peng J; Lin Y; Zhong N; Zhang G; Zhang T
    Microbiol Spectr; 2022 Aug; 10(4):e0276321. PubMed ID: 35946941
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Yu X; Gao X; Li C; Luo J; Wen S; Zhang T; Ma Y; Dong L; Wang F; Huang H
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31138571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of Mycobacterium tuberculosis resistant to bedaquiline and delamanid in China.
    He W; Liu C; Liu D; Ma A; Song Y; He P; Bao J; Li Y; Zhao B; Fan J; Cheng Q; Zhao Y
    J Glob Antimicrob Resist; 2021 Sep; 26():241-248. PubMed ID: 34214699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluating the effect of clofazimine against Mycobacterium tuberculosis given alone or in combination with pretomanid, bedaquiline or linezolid.
    Kim S; Louie A; Drusano GL; Almoslem M; Kim S; Myrick J; Nole J; Duncanson B; Peloquin CA; Scanga CA; Yamada W; Neely M; Schmidt S
    Int J Antimicrob Agents; 2022 Feb; 59(2):106509. PubMed ID: 34958863
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Aragaw WW; Cotroneo N; Stokes S; Pucci M; Critchley I; Gengenbacher M; Dick T
    Microbiol Spectr; 2022 Feb; 10(1):e0132121. PubMed ID: 35019671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and Antimicrobial Susceptibility of Mycobacterium abscessus in a General Hospital, China.
    Li YM; Tong XL; Xu HT; Ju Y; Cai M; Wang C
    Biomed Environ Sci; 2016 Feb; 29(2):85-90. PubMed ID: 27003165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High clustering rate and genotypic drug-susceptibility screening for the newly recommended anti-tuberculosis drugs among global extensively drug-resistant
    Trisakul K; Nonghanphithak D; Chaiyachat P; Kaewprasert O; Sakmongkoljit K; Reechaipichitkul W; Chaiprasert A; Blair D; Clark TG; Faksri K
    Emerg Microbes Infect; 2022 Dec; 11(1):1857-1866. PubMed ID: 35792049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in the Prevalence and Antibiotic Resistance of Non-tuberculous Mycobacteria in Mainland China, 2000-2019: Systematic Review and Meta-Analysis.
    Zhou L; Xu D; Liu H; Wan K; Wang R; Yang Z
    Front Public Health; 2020; 8():295. PubMed ID: 32850570
    [No Abstract]   [Full Text] [Related]  

  • 36. Prevalence of nontuberculous mycobacteria and high efficacy of d-cycloserine and its synergistic effect with clarithromycin against
    Khosravi AD; Mirsaeidi M; Farahani A; Tabandeh MR; Mohajeri P; Shoja S; Hoseini Lar KhosroShahi SR
    Infect Drug Resist; 2018; 11():2521-2532. PubMed ID: 30573983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nontuberculous Mycobacterial Lung Diseases Caused by Mixed Infection with Mycobacterium avium Complex and Mycobacterium abscessus Complex.
    Shin SH; Jhun BW; Kim SY; Choe J; Jeon K; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30104265
    [No Abstract]   [Full Text] [Related]  

  • 38. Bedaquiline resistance pattern in clofazimine-resistant clinical isolates of tuberculosis patients.
    Shang Y; Chen S; Shi W; Nie W; Jing W; Huo F; Xue Y; Dong L; Jiang G; Huang H; Chu N
    J Glob Antimicrob Resist; 2023 Jun; 33():294-300. PubMed ID: 37142094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and Effectiveness of Clofazimine for Primary and Refractory Nontuberculous Mycobacterial Infection.
    Martiniano SL; Wagner BD; Levin A; Nick JA; Sagel SD; Daley CL
    Chest; 2017 Oct; 152(4):800-809. PubMed ID: 28483608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigating Nontuberculous Mycobacteria Transmission at the Colorado Adult Cystic Fibrosis Program.
    Gross JE; Caceres S; Poch K; Hasan NA; Jia F; Epperson LE; Lipner E; Vang C; Honda JR; Strand M; Calado Nogueira de Moura V; Daley CL; Strong M; Davidson RM; Nick JA
    Am J Respir Crit Care Med; 2022 May; 205(9):1064-1074. PubMed ID: 35085056
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.